Press Release
Article
Those recognized were selected by a panel of judges from more than 15,000 customer-submitted entries in October 2018, during American Pharmacists Month.
Rite Aid has selected 6 members of its pharmacy team from across the country for recognition through the company’s annual Pharmacy Champions program.
Those recognized were selected by a panel of judges from more than 15,000 customer-submitted entries in October 2018, during American Pharmacists Month. Customers nationwide were asked to acknowledge and thank Rite Aid pharmacy team members that provided exceptional, personal, health-related service.
"At Rite Aid, our pharmacists and pharmacy teams put the patient at the center of everything they do, to deliver unmatched value-based care," said Jocelyn Konrad, Rite Aid executive vice president of pharmacy and retail operations, in a prepared statement. "This program is just 1 reminder of the impact our teams have on the lives and health outcomes of our customers."
The following Rite Aid employees are winners of the Pharmacy Champions contest:
According to Konrad, Rite Aid received an “overwhelming” number of entries for this year’s contest that highlighted pharmacy team members delivering best-in-class care to patients.
“[It is] something that is invaluable to our patients and Rite Aid,” she said. “We are extremely proud of our pharmacy team and thank all of our customers who took the time to nominate them.”
Each of the recognized team members will receive $2,500 in Rite Aid gift cards and the ability to designate a KidCents charity that will receive a $2,500 donation from The Rite Aid Foundation.
In addition, the 6 customers who nominated those selected team members will each receive $2,500 in Rite Aid gift cards.
Rite Aid will also recognize its "Pharmacy Champions" through a full-page ad in Pharmacy Times.
Reference
Rite Aid Recognizes Six Pharmacy Team Members for Outstanding Service Through Its Annual Pharmacy Champions Program [news release]. Camp Hill, Pennsylvania; May 7, 2019: Rite Aid. [email] Accessed May 7, 2019.
Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval